Jiangsu Hengrui reported CNY58.69B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Cspc Pharmaceutical CNY 32.26B 2.59B Dec/2024
Kangmei Pharma CNY 7.73B 546.26M Jun/2025
Sh Fosun Pharma CNY 48.07B 149.08M Jun/2025
Sh Pharmaceutical CNY 88.86B 15.85B Jun/2025
Sino Biopharmaceutical CNY 31.96B 884.2M Dec/2024
Wuxi Apptec CNY 59.91B 2.42B Jun/2025
Zz Pientze Pharmaceu 14.65B 617.48M Jun/2025